Electra Therapeutics IPO Signals Market Caution for Clinical-Stage Biotech
Electra Therapeutics raises $350 million in an upsized IPO, but a flat opening day underscores the cooling appetite for high-burn clinical-stage biotech assets.
VentureGrill 3 min read